LYEL Shares Outstanding History Table | ||||||||||||||||||||||||||||||
Also see: LYEL Market Cap History LYEL YTD Return |
LYEL Shares Outstanding History Table | ||||||||||||||||||||||||||||||
Also see: LYEL Market Cap History LYEL YTD Return |
LYEL Shares Outstanding History Chart | |||||||||||||||||||||||||||||||
+4.20% CAGR ![]() Mouse over chart for data details
|
LYEL Stock Price Chart |
About Lyell Immunopharma Inc |
Lyell Immunopharma, Inc. is a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for patients with solid tumors. Co. is engaged in enrolling a Phase I clinical trial evaluating a ROR1-targeted CAR T-cell therapy in patients with relapsed refractory triple-negative breast cancer and non-small cell lung cancer (NSCLC) and a second Phase I clinical trial evaluating reprogrammed tumor infiltrating lymphocytes (TIL) in patients with advanced melanoma, NSCLC and colorectal cancer. We show 14 historical shares outstanding datapoints in our coverage of LYEL's shares outstanding history. Understanding the changing numbers of LYEL shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like LYEL versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching LYEL by allowing them to research LYEL shares outstanding history as well as any other stock in our coverage universe. |
LYEL Current Stock Quote |
![]() Get Dividend Alerts ![]() Get SEC Filing Alerts ![]() |
Video: Shares Outstanding Importance | |
|
LYEL Share Performance |
Shares Outstanding Peers |
Lyell Immunopharma (LYEL) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
LYRA Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.